Likewise, in China, Gendicine is an approved recombinant p53 adenovirus gene therapy product that was initially administered in combination with radiotherapy to treat head and neck cancer, but it has now also been reported effective in other cancers [136]. The gene discussed is TP53; the disease is cancer.